Xencor | XNCR - Current Assets

Stock Price
11.22
Daily Change
-0.66 -5.56%
Monthly
-9.88%
Yearly
39.21%
Q2 Forecast
10.99

Xencor reported $482.85M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
AbbVie USD 33.53B 4.47B Mar/2026
Alnylam Pharmaceuticals USD 4.22B 168.65M Mar/2026
Amgen USD 31.48B 2.42B Mar/2026
Arrowhead Research USD 1.84B 665.36M Mar/2026
AstraZeneca USD 29.61B 890M Mar/2026
Biogen USD 9.19B 216.3M Mar/2026
Bristol-Myers Squibb USD 27.21B 2.18B Mar/2026
Cytokinetics USD 839.46M 77.51M Mar/2026
GlaxoSmithKline GBP 17.76B 251M Mar/2026
J&J USD 59.17B 3.55B Mar/2026
Karyopharm Therapeutics USD 103.15M 13.4M Dec/2025
MacroGenics USD 182.52M 37.42M Mar/2026
Merck USD 35.02B 8.5B Mar/2026
Novartis USD 26.61B 3.85B Mar/2026
Pfizer USD 42.82B 76M Mar/2026
Regeneron Pharmaceuticals USD 18.21B 187.3M Mar/2026
Roche Holding CHF 38.73B 3.03B Dec/2025
Xencor USD 482.85M 116.97M Mar/2026